Covered recipient · General Payments record
SHILPA REDDY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,158.02
- Reported across 176 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $558.07 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $379.36 | 26 |
| Gilead Sciences, Inc. | $39.56 | 2 |
| Medtronic, Inc. | $38.17 | 1 |
| Lilly USA, LLC | $30.24 | 2 |
| Braintree Laboratories, Inc. | $22.28 | 1 |
| Ardelyx, Inc. | $19.11 | 1 |
| INTERCEPT PHARMACEUTICALS, INC. | $15.10 | 1 |
| PFIZER INC. | $14.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.92 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929551 | CMS |
| ABBVIE INC. | $20.38 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929553 | CMS |
| ABBVIE INC. | $6.27 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929555 | CMS |
| ABBVIE INC. | $19.65 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929557 | CMS |
| ABBVIE INC. | $20.79 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929559 | CMS |
| ABBVIE INC. | $23.45 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929561 | CMS |
| ABBVIE INC. | $7.92 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929563 | CMS |
| ABBVIE INC. | $21.14 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929565 | CMS |
| ABBVIE INC. | $13.24 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929567 | CMS |
| ABBVIE INC. | $7.59 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929569 | CMS |
| ABBVIE INC. | $14.68 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929571 | CMS |
| ABBVIE INC. | $15.71 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929573 | CMS |
| ABBVIE INC. | $11.80 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929575 | CMS |
| ABBVIE INC. | $22.51 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929577 | CMS |
| ABBVIE INC. | $15.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929579 | CMS |
| ABBVIE INC. | $9.71 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929581 | CMS |
| ABBVIE INC. | $13.63 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929583 | CMS |
| ABBVIE INC. | $13.56 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929585 | CMS |
| ABBVIE INC. | $17.26 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929587 | CMS |
| ABBVIE INC. | $6.18 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929589 | CMS |
| ABBVIE INC. | $12.12 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929591 | CMS |
| ABBVIE INC. | $8.05 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929593 | CMS |
| ABBVIE INC. | $18.05 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929595 | CMS |
| ABBVIE INC. | $13.03 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929597 | CMS |
| ABBVIE INC. | $18.58 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929599 | CMS |
| ABBVIE INC. | $21.12 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105929601 | CMS |
| Ardelyx, Inc. | $19.11 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146703448 | CMS |
| Braintree Laboratories, Inc. | $22.28 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125517241 | CMS |
| Gilead Sciences, Inc. | $21.69 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133637977 | CMS |
| Gilead Sciences, Inc. | $17.87 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133637979 | CMS |
| Intercept Pharmaceuticals, Inc. | $15.10 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113642779 | CMS |
| Lilly USA, LLC | $13.87 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135376594 | CMS |
| Lilly USA, LLC | $16.37 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135408659 | CMS |
| Medtronic, Inc. | $38.17 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117167754 | CMS |
| PFIZER INC. | $14.25 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132099489 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.